Intercept Pharmaceuticals Competitors and Similar CompaniesClear all
Intercept Pharmaceuticals's competitors and similar companies include Promethera Biosciences.
 Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. |  Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | |
Founding Date | Founding Date 2002 | Founding Date 2009 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more |
Employees | Employees 58321% increase | Employees 185% decrease |
Funding | ||
Total funding raised | Total funding raised $ 55m | Total funding raised $ 146m |
For sources of this data, please see the company profile
View Company Profiles
Promethera Biosciences
HQ
Mont-Saint-Guibert, BE
Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.
View company